MALAT1 and neoplasm: It was suggested that high expression of MALAT1 was significantly correlative to LSCC patients who were characterized by large tumor size (>2 cm), advanced TNM grade (III‐IV), and metastatic lymph nodes (P < .05) (Table 1).